UCENTRO Trademark

Trademark Overview

On Monday, June 24, 2019, a trademark application was filed for UCENTRO with the United States Patent and Trademark Office. The USPTO has given the UCENTRO trademark a serial number of 88487127. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, June 5, 2023. This trademark is owned by Sunovion Pharmaceuticals Inc.. The UCENTRO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for treating central nervous system diseases or disorders; pharmaceutical preparations for treating attention-deficit/hyperactivity disorder (ADHD); pharmaceutical preparations for treating eating disorders
ucentro

General Information

Serial Number88487127
Word MarkUCENTRO
Filing DateMonday, June 24, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, June 5, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 10, 2020

Trademark Statements

Goods and ServicesPharmaceutical preparations for treating central nervous system diseases or disorders; pharmaceutical preparations for treating attention-deficit/hyperactivity disorder (ADHD); pharmaceutical preparations for treating eating disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, July 4, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSunovion Pharmaceuticals Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMarlborough, MA 01752
Party NameSunovion Pharmaceuticals Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMarlborough, MA 01752

Trademark Events

Event DateEvent Description
Monday, June 5, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, June 5, 2023ABANDONMENT - NO USE STATEMENT FILED
Wednesday, November 9, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 8, 2022SOU EXTENSION 5 GRANTED
Tuesday, November 1, 2022SOU EXTENSION 5 FILED
Tuesday, November 8, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, November 1, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, May 4, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 2, 2022SOU EXTENSION 4 GRANTED
Monday, May 2, 2022SOU EXTENSION 4 FILED
Monday, May 2, 2022SOU TEAS EXTENSION RECEIVED
Thursday, October 28, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 26, 2021SOU EXTENSION 3 GRANTED
Tuesday, October 26, 2021SOU EXTENSION 3 FILED
Tuesday, October 26, 2021SOU TEAS EXTENSION RECEIVED
Thursday, May 6, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 4, 2021SOU EXTENSION 2 GRANTED
Tuesday, May 4, 2021SOU EXTENSION 2 FILED
Tuesday, May 4, 2021SOU TEAS EXTENSION RECEIVED
Thursday, January 7, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, January 7, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, January 7, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, January 7, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, January 7, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, January 7, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Saturday, November 7, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 5, 2020SOU EXTENSION 1 GRANTED
Thursday, November 5, 2020SOU EXTENSION 1 FILED
Thursday, November 5, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, May 5, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 10, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 10, 2020PUBLISHED FOR OPPOSITION
Wednesday, February 19, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, February 5, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, November 18, 2019NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, November 18, 2019LETTER OF SUSPENSION E-MAILED
Monday, November 18, 2019SUSPENSION LETTER WRITTEN
Wednesday, October 23, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, October 23, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, October 23, 2019ASSIGNED TO LIE
Thursday, October 17, 2019TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Tuesday, September 17, 2019NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, September 17, 2019LETTER OF SUSPENSION E-MAILED
Tuesday, September 17, 2019SUSPENSION LETTER WRITTEN
Friday, September 13, 2019ASSIGNED TO EXAMINER
Thursday, July 4, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, June 27, 2019NEW APPLICATION ENTERED

Related Keywords

ucentro pharmaceutical treating preparations disorders hyperactivity adhd eating deficit disorder diseases